Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

The iShares Biotechnology ETF (IBB) is navigating a critical juncture, with conflicting signals emerging from market ...

The iShares Biotechnology ETF is up over 32% in six months on rate cut expectations and potential sector rotation. The State Street SPDR S&P Biotech ETF has surged 45% in six months but remains 27% ...

Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied about 35% over the past six months (as of Nov. 20, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 12%). Year to ...

Stop me if you’ve heard this before: Exchange-traded funds enjoyed another banner year. Strong markets and relentless inflows continued to raise the bar for ETFs. ETFs collected over $1 trillion in ...

Forbes contributors publish independent expert analyses and insights. I'm a journalist who covers finance and investing. Nov 29, 2025, 05:01pm EST Global ETF asset growth as at end of September 2025.

When you buy an index fund, you are buying a portfolio with real shares in weights that reflect a miniature version of the underlying market or index (see here and here for more). We also know that if ...

Some growth ETFs are riskier than others, but all are designed to earn greater returns over the long term. From tech-focused funds to mega-cap growth ETFs, these investments can supercharge your ...